Showing results (71-80 of 113) with videos related to
Sort By:
Pageof 12
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 12, 2021
Perianal Crohn's Disease Is Associated With Poor Disease Outcome: A Nationwide Study From the epiIIRN CohortOhad Atia, Noa Asayag, Gili Focht, et al.Scientific Reports|March 5, 2021
Heterozygous APC germline mutations impart predisposition to colorectal cancerLivia Preisler, Aline Habib, Guy Shapira, et al.Alimentary Pharmacology & Therapeutics|March 9, 2023
5-aminosalicylate maintenance is not superior to no maintenance in patients with newly diagnosed Crohn's disease-A nationwide cohort studyOhad Atia, Idan Goren, Tali Sharar Fischler, et al.Journal of Molecular Medicine (Berlin, Germany)|December 2, 2015
A flow cytometry-based reporter assay identifies macrolide antibiotics as nonsense mutation read-through agentsMichal Caspi, Anastasia Firsow, Raja Rajkumar, et al.Inflammatory Bowel Diseases|April 21, 2023
Prevalence and Outcomes of No Treatment Versus 5-ASA in Ulcerative Colitis: A Nationwide Analysis From the epi-IIRNOhad Atia, Ramit Magen Rimon, Natan Ledderman, et al.Journal of Pediatric Gastroenterology and Nutrition|February 15, 2021
Pediatric-onset Inflammatory Bowel Disease Has Only a Modest Effect on Final Growth: A Report From the epi-IIRNAmit Assa, Noa Assayag, Ran D Balicer, et al.Journal of Crohn'S & Colitis|November 18, 2021
Risk of Cancer in Paediatric onset Inflammatory Bowel Diseases: A Nation-wide Study From the epi-IIRNOhad Atia, Sasha Harel, Natan Ledderman, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 26, 2021
COVID-19 Vaccine Is Effective in Inflammatory Bowel Disease Patients and Is Not Associated With Disease ExacerbationRaffi Lev-Tzion, Gili Focht, Rona Lujan, et al.Journal of Crohn'S & Colitis|April 21, 2023
Association of Antibiotic Use with Durability of Biologic Agents in Inflammatory Bowel Disease: a Report from the epi-IIRNYuri Gorelik, Itai Ghersin, Deema Shlon, et al.International Journal of Cancer|June 19, 2019
5-Hydroxymethylcytosine as a clinical biomarker: Fluorescence-based assay for high-throughput epigenetic quantification in human tissuesSapir Margalit, Sigal Avraham, Tamar Shahal, et al.Pageof 12